1. 236. Treatment of Recurrent Clostridioides difficile Infection With RBX2660 in Patients ≥ 65 Years Old With Underlying Comorbidities. (15th December 2022) Authors: Tillotson, Glenn S; Feuerstadt, Paul; Archbald-Pannone, Laurie; Archbald-Pannone, Laurie; Johnson, Stuart; Ng, Samson; Ando, Masakazu; Harvey, Adam Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 522. Significant Improvement in Health-Related Quality of Life (HRQL) with RBX2660: Results from a Phase 3 Randomized, Placebo-Controlled Trial in Recurrent Clostridioides Difficile Infection (PUNCH CD3). (15th December 2022) Authors: Feuerstadt, Paul; Dubberke, Erik R; Guo, Amy; Harvey, Adam; Yang, Min; García-Horton, Viviana; Fillbrunn, Mirko; Tillotson, Glenn S; Bancke, Lindy; Garey, Kevin W Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A new dawn for the management of influenza?. Issue 10 (October 2020) Authors: Tillotson, Glenn S Journal: Lancet infectious diseases Issue: Volume 20:Issue 10(2020) Page Start: 1112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antibiotic dosing: do we dose to cure the individual or do we treat the greater societal needs?. Issue 4 (July 2005) Authors: Blondeau, Joseph M; Tillotson, Glenn S Journal: Therapy Issue: Volume 2:Issue 4(2005) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antibiotic resistance: the challenge from an industry perspective. Issue 2 (March 2009) Authors: Tillotson, Glenn S Journal: Expert review of clinical pharmacology Issue: Volume 2:Issue 2(2009) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study. Issue 1 (1st January 2017) Authors: Llop, Christopher J; Tuttle, Edward; Tillotson, Glenn S; LaPlante, Kerry; File, Thomas M Journal: Hospital practice Issue: Volume 45:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clostridium difficile : new challenges for an old foe /: new challenges for an old foe. ([2013]) Editors: Tillotson, Glenn S; Weiss, Karl, 1964- Other Names: Future Medicine Ltd. Record Type: Book Extent: 1 PDF (151 pages), color illustrations, digital file View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effect of fecal microbial transplantation on Clostridioides difficile infection: dysbiosis, metabolites and health related quality of life. (24th March 2023) Authors: Garey, Kevin W; Feuerstadt, Paul; Dubberke, Erik R; Guo, Amy; Tillotson, Glenn S Journal: Open forum infectious diseases Issue: Volume 10:Number 3(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. Issue 7 (July 2017) Authors: Vickers, Richard J; Tillotson, Glenn S; Nathan, Richard; Hazan, Sabine; Pullman, John; Lucasti, Christopher; Deck, Kenneth; Yacyshyn, Bruce; Maliakkal, Benedict; Pesant, Yves; Tejura, Bina; Roblin, David; Gerding, Dale N; Wilcox, Mark H; Bhan, Amit; Campbell, Wayne; Chopra, Teena; Deck, Kenneth; ... Journal: Lancet infectious diseases Issue: Volume 17:Issue 7(2017:Jul.) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. Issue 7 (July 2017) Authors: Vickers, Richard J; Tillotson, Glenn S; Nathan, Richard; Hazan, Sabine; Pullman, John; Lucasti, Christopher; Deck, Kenneth; Yacyshyn, Bruce; Maliakkal, Benedict; Pesant, Yves; Tejura, Bina; Roblin, David; Gerding, Dale N; Wilcox, Mark H Journal: Lancet infectious diseases Issue: Volume 17:Issue 7(2017:Jul.) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗